Recent Articles from GlobeNewswire

SHANGHAI, China, Jan. 30, 2026 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced a private placement of US$300 million of Series B convertible preferred shares (the “convertible preferred shares”) to Huatai Capital Investment Limited, a Chinese institutional investor (the “Private Placement”). GDS will use the proceeds from the private placement to fund expansion of its data center capacity and for general corporate purposes.

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com

PHOENIX, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, has declared under its dividend policy a monthly cash dividend in the amount of $0.02533 per common share (an annual dividend rate of $0.30396 per share).

SOUTH SAN FRANCISCO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (“ALX Oncology,” Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced the pricing of an underwritten offering of common stock and pre-funded warrants. ALX Oncology is selling 76,979,112 shares of common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase 18,574,120 shares of common stock in the offering. The shares of common stock are being sold at an offering price of $1.57 per share, the closing price on January 29, 2026, and the pre-funded warrants are being sold at an offering price of $1.569 per pre-funded warrant, which represents the per share offering price for each share of common stock less the $0.001 per share exercise price for each pre-funded warrant. The gross proceeds to ALX Oncology from this offering are expected to be approximately $150 million, before deducting the underwriting discounts and commissions and other estimated offering expenses, and excluding the exercise of any pre-funded warrants. All shares of common stock and pre-funded warrants to be sold in the offering are being offered by ALX Oncology. The offering is expected to close on or about February 2, 2026, subject to the satisfaction of customary closing conditions.

NEW YORK, NY, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Saratoga Investment Corp. (the “Company”) (NYSE: SAR) today announced that it has priced an underwritten public offering of $100.0  million in aggregate principal amount of 7.50% unsecured notes due 2031 (the “Notes”). The offering is subject to customary closing conditions and is expected to close on February 6, 2025.

Company expects up to six-month review period per FDA guidelines 

Policy growth reflects strong execution and expanding distribution across RELI Exchange platform

CHARLOTTE, N.C., Jan. 30, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to present its quarterly report for the period ending December 31, 2025. Highlights during and subsequent to the end of the quarter include:

NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI), today announced the Company will hold a conference call to review its fourth quarter and full year 2025 financial results on Wednesday, February 11, 2026 at 10:00 a.m. Eastern Time. The Company’s fourth quarter and full year 2025 financial results will be released after the market closes on Tuesday, February 10, 2026. During the conference call, Company officers will review fourth quarter and full year 2025 performance, discuss recent events and conduct a question-and-answer period.

WISeSat.Space Brought Together Global Thought-Leaders to Davos to Address Quantum Security in Space

PHILADELPHIA, Jan. 30, 2026 (GLOBE NEWSWIRE) --

VIO Med Spa selected as a key med spa franchise partner for its commitment to clinical excellence, innovation, and nationwide scalable aesthetic care

Expanded Distribution Builds on Existing Relationship and Strengthens Regional Retail Presence

PHILADELPHIA, Jan. 30, 2026 (GLOBE NEWSWIRE) -- WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Lifecore Biomedical, Inc. (NASDAQ: LFCR) as a securities fraud class action has now reached a settlement. The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

- Exploratory analysis from Phase 1b/2 breast cancer trial reinforces CD47 as a predictive biomarker for response, as previously observed in the ASPEN-06 trial in HER2-positive gastric cancer –

The Free, Live Daily Mobile Game Challenges Players to Guess Real Home Listing Prices in Order to Win Free Rent or Mortgage 

PARAMUS, NJ, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics (“Polaryx” or the “Company”) a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), today announced that shares of the Company’s common stock have been approved for listing on the Nasdaq Capital Market (“Nasdaq”) under the ticker symbol “PLYX”. Shares of Polaryx common stock are expected to commence trading on or about February 2, 2026.

ZEELAND, Mich., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Gentex Corporation (NASDAQ: GNTX), a leading supplier of digital vision, connected car, dimmable glass, fire protection technologies, medical devices, and consumer electronics, today reported financial results for the fourth quarter and calendar year ended December 31, 2025.

TOKYO and PRINCETON, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), a Japan-based global specialty pharmaceutical company, today announced the termination of the current rocatinlimab development and commercialization collaboration with Amgen. Kyowa Kirin will regain control of the global rocatinlimab program, including regulatory filings and future commercialization. This business decision is the result of a strategic portfolio prioritization by Amgen. The companies are initiating a smooth and orderly transition of the program, with a focus on ensuring continuity for participants currently enrolled in clinical trial programs. Amgen, who has partnered with Kyowa Kirin on numerous investigational therapies over 41 years, will continue to manufacture rocatinlimab.

HONOLULU, Jan. 30, 2026 (GLOBE NEWSWIRE) -- First Hawaiian, Inc. (NASDAQ:FHB), (“First Hawaiian” or the “Company”) today reported financial results for its quarter ended December 31, 2025.

SOUTH SAN FRANCISCO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to purchase an aggregate of 81,100 shares of the Company’s stock (the “Inducement Grant”) to newly hired employees on January 29, 2026 (the “Grant Date”), in connection with the commencement of employment.

BELVIDERE, NJ, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce,  today announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-10. The reverse stock split will take effect as of 12:01 a.m. ET, on February 3, 2026, and shares of Edible Garden will trade on a post-split basis on Nasdaq under the existing trading symbol, “EDBL,” at the market open on February 3, 2026.

KUALA LUMPUR, Malaysia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc. (“Alps Holdco”), a fully integrated biotechnology research and healthcare platform specializing in predictive, preventive, and precision medicine, today announced a potential expansion of its exosome-related pipeline beyond its previously disclosed CELESOME(+) program. The announcement follows the publication of a preliminary retrospective clinical case series in SAGE Open Medical Case Reports describing nebulized human umbilical cord mesenchymal stem cell (“hUCMSC”) derived exosome in patient with asthma and/or chronic obstructive pulmonary disease (“COPD“). The clinical case series study was registered with the National Medical Research Register, Ministry of Health Malaysia (NMRR ID-25-00600-F4A).

DALLAS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Westwood Holdings Group, Inc. (NYSE:WHG) will release its fourth quarter and fiscal year 2025 earnings after the close of the New York Stock Exchange on Friday, February 13, 2026. Following the release, the Company will host a live audio webcast and conference call at 4:30 pm Eastern Time (3:30 pm Central Time).

Goranson Bain Ausley, a leading Texas family law firm, announced that Jill Lowe has joined the firm as a family law attorney, bringing more than 21 years of legal experience and a strong focus on collaborative, settlement-focused divorce.

South San Francisco, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- The California Institute for Regenerative Medicine (CIRM) has approved a new funding program to accelerate therapies for rare diseases, which sets aside $100 million over two years to create a scalable model that rapidly delivers transformative, platform-based genetic therapies for the millions of people in the U.S. living with rare diseases. The Rare Disease Acceleration Platform and Innovation and Delivery (RAPID) program builds on the recent success of a genetic therapy developed in six months for Baby KJ, the first infant successfully treated for a rare, life-threatening disorder called CPS1 deficiency.  

New York, NY, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Horizon Space Acquisition II Corp. (the “Company” or “HSPT”) (NASDAQ: HSPT) today announced that it postponed the extraordinary general meeting (the “Extraordinary Meeting”) originally scheduled at 9:00 a.m. Eastern Time, on February 3, 2026, to 9:00 a.m. Eastern Time, on February 12, 2026 (the “Postponement”) to allow the Company additional time to engage with its shareholders.

Extends cash runway into 2028

TORONTO, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Centerra Gold Inc. (“Centerra” or the “Company”) (TSX: CG) (NYSE: CGAU) has suspended operations at its Langeloth Metallurgical Facility (“Langeloth”) near Pittsburgh, Pennsylvania following an explosion on January 29, 2026 at approximately 6:15 p.m. Eastern Time, which was a result of an uncontrolled mixture of chemicals leading to an uncontained chemical reaction adjacent to the acid plant. No fatalities were reported, but two contractors were taken to hospital with injuries, and two employees were taken to hospital for precautionary reasons. Presently, there is no indication of a significant environmental release. The relevant regulatory agencies and authorities have been notified. The Company is currently assessing Langeloth’s estimated downtime and will provide an update when more information is available.

MONTREAL, Jan. 30, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) announced today that its Board of Directors has approved a 3% increase in the 2026 dividend on the Company's outstanding common shares as well as the repurchase of its shares under a new normal course issuer bid (Bid).

MONTREAL, Jan. 30, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) today reported its financial and operating results for the fourth quarter and year ended December 31, 2025.

Live webcast at 8:30 a.m. EST

JAKARTA, Indonesia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Society Pass Incorporated (Nasdaq: SOPA) (the “Company”), Southeast Asia’s next generation digital ecosystem, and its majority owned subsidiary, NusaTrip Inc (Nasdaq: NUTR) (“NusaTrip”), the leading Southeast Asia (“SEA”) and Asia-Pacific-based (“APAC”) integrated travel technology platform, today announces that NusaTrip has formed a strategic partnership with Search Engine Optimization Company Limited (“Gother”), a fast-growing online travel agency in Thailand. Under this agreement, NusaTrip will supply flight content to Gother, enhancing air travel distribution in Thailand and throughout Southeast Asia. This partnership further strengthens NusaTrip’s position as a leading flight content supplier in the regional travel market.

MONTRÉAL, Jan. 30, 2026 (GLOBE NEWSWIRE) -- OR Royalties Inc. (“OR Royalties” or the “Company”) (OR: TSX & NYSE) is pleased to announce the appointment of Mr. Kevin Thomson as an Independent Director to its Board of Directors (the “Board”).Concurrently, the Company announces that Mr. William Murray John has resigned as a director of the Company, effective immediately.

− Phase 2 Data Strengthened, Strong Cash Position, and Phase 3 Planning Well Advanced −

NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Luvme Hair, a trusted brand of human hair wigs and half wigs, introduced the All-Day Curl Hold™ Wig, a new release designed to support longer-lasting curl definition. The product uses healthier-sourced human hair from Southeast Asia and is finished with Luvme’s SilkShield™ Care Process (gentle acid cleanse, purified-water rinse, and protein conditioning infusion) to help keep hair smooth and resilient with proper care. The launch also features Wash-back Polish, which combines the CuticleAlign™ Method with SilkShield™ to help maintain a polished look and manageability over multiple washes.

SINGAPORE, Jan. 30, 2026 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd. (NASDAQ: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced its financial results for the six months ended September 30, 2025.

Reimagining Retail to Address a Multi-Trillion-Dollar Market Opportunity with Fully Autonomous Smart Stores

ORLANDO, Fla., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) has provided an update to shareholders on the key milestones and discussions from this years Annual Shareholders Meeting, held on Jan 24, 2026 in Orlando, Florida. Details and highlights may be found below.

Dubai and Ottawa, January 30, 2026:  VEON Ltd. (NASDAQ: VEON), a global digital operator, and MindBridge, the leader in AI-powered financial intelligence, today announced a strategic collaboration to deploy artificial intelligence-powered analytics tools across VEON’s global operations.

NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Emerita Resources Corp. (TSX-V: EMO; OTCQX: EMOTF), a natural resource company, has qualified to trade on the OTCQX® Best Market. Emerita Resources Corp. upgraded to OTCQX from the OTCQB® Venture Market.

Immunocore announces R&D leadership evolution

Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease

NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced AltaGas Ltd. (TSX: ALA; OTCQX: ATGFF), a leading North American infrastructure company, has qualified to trade on the OTCQX® Best Market. AltaGas Ltd. upgraded to OTCQX from the Pink Limited™ Market.

This news release constitutes a “designated news release” for the purposes of the prospectus supplement dated January 12, 2026 to the short form base shelf prospectus of Brookfield Renewable Partners L.P. and Brookfield Renewable Corporation dated January 23, 2025.

TORONTO, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) today reported new results from its underground exploration program at the Young-Davidson mine. Underground exploration drilling from both the mid and lower mine extended higher-grade gold mineralization within multiple zones in the hanging wall of the Young-Davidson deposit. In addition, expansion drilling within the Young-Davidson syenite continues to extend gold mineralization beyond Mineral Reserves and Mineral Resources.

HAMILTON, BERMUDA, January 30, 2026 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today announces that it has entered into an agreement to sell the DHT Bauhinia, built in 2007, for a price of $51.5 million. The vessel is expected to be delivered to the new owner during June/July 2026. The vessel is debt free and the Company expects to record a gain of $34.2 million related to the sale.

A cost-effective LTE Cat 1bis portfolio designed for scalable, flexible, and power-efficient IoT deployments

BROOKFIELD, News, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Brookfield Business Partners (NYSE: BBU, BBUC; TSX: BBU.UN, BBUC) announced today financial results for the year ended December 31, 2025.

Strong Fourth-Quarter Results and 2026 Guidance Reflect Impact of Bold Actions and Beginning of Verizon's Turnaround 

HOUSTON and LONDON, Jan. 30, 2026 (GLOBE NEWSWIRE) -- LyondellBasell Industries (NYSE: LYB) today announced results for the fourth quarter and full year 2025. Comparisons with the prior quarter, fourth quarter 2024 and full year 2024 are available in the following table:

TARRYTOWN, N.Y., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for the fourth quarter and full year 2025 and provided a business update.

SOUTH BEND, Ind., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) (the “Company”) announced today that it will report its year-end 2025 financial results on February 19, 2026, after the close of market.

SANTIAGO, Chile, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its results1 for the twelve-month period ended December 31, 2025, and fourth quarter 2025 (4Q25).

Additional investment builds on EF’s existing commitment and will go towards building Tour de France Femmes winning squad and long-term talent development on men’s and U23 squads

$10 million investment values 4Divinity publishing subsidiary at $250 million

THE WOODLANDS, Texas, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”) today announced the pricing of its previously announced underwritten public offering of 32,000,000 shares of its common stock, par value $0.001. The shares of common stock being offered pursuant to the public offering are being offered at a public offering price of $1.30 per share. All of the shares are being offered by Lexicon. The gross proceeds from the public offering are expected to be $41.6 million, before deducting underwriting discounts and commissions and other offering expenses. The public offering is expected to close on or about February 2, 2026, subject to the satisfaction of customary closing conditions. In addition, Lexicon has granted the underwriters a 30-day option to purchase up to an additional 4,800,000 shares of common stock at the public offering price, less underwriting discounts and commissions.

30 January 2026, 08:30 CET

QUEBEC CITY, Jan. 30, 2026 (GLOBE NEWSWIRE) -- West African gold producer and developer Robex Resources Inc. (“Robex” or the “Company”) (TSX-V: RBX | ASX: RXR | OTC: RSRBF | Börse Frankfurt: RB4) is pleased to report on its activities for the December 2025 quarter.

SAN CARLOS, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, announced today the pricing of an underwritten public offering of common stock. Vaxcyte is selling 11,000,000 shares of common stock in the offering at a public offering price of $50.00 per share. The aggregate gross proceeds to Vaxcyte from this offering are expected to be $550 million, before deducting underwriting discounts and commissions and other offering expenses. All shares of common stock to be sold in the offering will be offered by Vaxcyte. Vaxcyte has granted the underwriters a 30-day option to purchase up to an additional 1,650,000 shares of its common stock at the public offering price per share, less underwriting discounts and commissions.

CGTN published an article on UK Prime Minister Keir Starmer's visit to China, highlighting that amid rising global uncertainty, Beijing and London are placing greater emphasis on long-term stability, pragmatic cooperation and shared interests in global governance and economic growth.

Shanghai Municipal Administration of Culture and Tourism

MONTREAL, Jan. 29, 2026 (GLOBE NEWSWIRE) -- We have taken note of the post from the President of the United States to social media and are in contact with the Canadian government. Bombardier is an international company that employs more than 3,000 people in the U.S. across 9 major facilities, and creates thousands of U.S. jobs through 2,800 suppliers. Our aircraft, facilities and technicians are fully certified to FAA standards and renowned around the world. We are actively investing in expanding our U.S. operations, including a recent announcement in Fort Wayne, Indiana.

LONG BEACH, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today successfully launched its 81st Electron rocket and second launch in eight days to deploy a satellite for an Earth-observation constellation by the Korea Advanced Institute of Science and Technology (KAIST), Korea’s leading university dedicated to science and technology.

NEW YORK, New York, January 29, 2026 -- VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or, together with its subsidiaries, the “VEON Group”) notes that Kyivstar Group Ltd. (Nasdaq: KYIV; KYIVW) (“Kyivstar” or the “Company”), Ukraine’s leading digital operator, today announced the pricing of the public offering of 12,100,000 common shares held by VEON Amsterdam B.V., the principal shareholder of the Company, and 400,000 common shares held by certain other selling shareholders (collectively, the “Selling Shareholders”) at a public offering price of USD 10.50 per share (the “Offering”). In connection with the Offering, the Selling Shareholders have granted the underwriters a 30-day option to purchase up to an additional 1,875,000 common shares at the public offering price, less underwriting discounts and commissions.

New York, Jan. 29, 2026 (GLOBE NEWSWIRE) -- M EVO GLOBAL ACQUISITION CORP II (the “Company”) announced today that it priced its initial public offering of 27,000,000 units at $10.00 per unit after upsizing the original offering of 22,500,000 units. The units will be listed on the Nasdaq Global Market ("Nasdaq") and will trade under the ticker symbol “MEVOU” beginning January 30, 2026. Each unit consists of one Class A ordinary share of the Company, $0.0001 par value per share, and one-half of one redeemable warrant, each whole warrant entitling the holder to purchase one Class A ordinary share upon exercise, at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the Nasdaq under the symbols “MEVOX” and “MEVOW,” respectively. The offering is expected to close on February 2, 2026, subject to customary closing conditions.

New York, New York, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Muzero Acquisition Corp (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company today announced the pricing of its initial public offering of 17,500,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share. The units are expected to trade on the Global Market tier of The Nasdaq Stock Market LLC (“Nasdaq”) under the ticker symbol “MUZEU” beginning January 30, 2026. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the ordinary shares and the warrants are expected to be traded on Nasdaq under the symbols “MUZE” and “MUZEW,” respectively.

JINAN, China, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Bodor Laser, a global manufacturer of laser cutting solutions, has announced the launch of its SK Series High-Speed Tube Laser Cutting Machine, alongside the introduction of its new “Extreme Speed” concept for tube processing. The concept focuses on improving overall manufacturing efficiency by combining high-speed performance, structural stability, and intelligent automation across the production process.

Washington, D.C., Jan. 29, 2026 (GLOBE NEWSWIRE) -- The National Minority Quality Forum (NMQF) today announced the launch of the COVID Care Club, a new patient-centered Facebook community designed to support individuals and families navigating COVID-19 and long COVID amid continued circulation of the virus and widespread confusion about vaccine guidance and care.

Preliminary Economic Assessment on Green Bay Copper-Gold Project on track for completion in the June 2026 quarter, highlighting the value of the world-scale Resource

NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) --

   New customer win underscores authID’s leadership in workforce verification and stopping AI-driven hiring fraud across global enterprises 

HONG KONG, CHINA, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Newbridge Acquisition Limited (NASDAQ: NBRG) (the "Company") announced today that it priced its initial public offering of 5,000,000 units at $10.00 per unit. The units are expected to be listed on the NASDAQ Capital Market ("NASDAQ") and trade under the ticker symbol "NBRGU" beginning January 30, 2026. Each unit consists of one Class A ordinary share and one right. Each right entitles the holder thereof to receive one-eighth (1/8) of one Class A ordinary share upon the consummation of an initial business combination. No fractional rights will be issued upon separation of the units. As a result, eight rights are needed to receive one Class A ordinary share at the closing of the initial business combination. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to be listed on NASDAQ under the symbols "NBRG" and "NBRGR", respectively.